PHRENILIN®: Each PHRENILIN® tablet for oral administration, contains Butalbital, USP 50 mg, Acetaminophen, USP 325 mg.
PHRENILIN® tablets and PHRENILIN® FORTE capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.
Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habitforming and potentially abusable.
Media Articles Related to Phrenilin (Butalbital / Acetaminophen)
Health Tip: Log Symptoms in a Headache Diary
Source: MedicineNet Headache Specialty [2015.07.01]
Title: Health Tip: Log Symptoms in a Headache Diary
Category: Health News
Created: 7/1/2015 12:00:00 AM
Last Editorial Review: 7/1/2015 12:00:00 AM
Migraine Headaches Pictures Slideshow: Celebrities With Migraines
Source: MedicineNet Beta Blockers Specialty [2015.06.30]
Title: Migraine Headaches Pictures Slideshow: Celebrities With Migraines
Created: 11/5/2012 12:00:00 AM
Last Editorial Review: 6/30/2015 12:00:00 AM
Migraine Headaches Pictures Slideshow: 14 Non-Drug Treatments for Migraines
Source: MedicineNet Beta Blockers Specialty [2015.06.26]
Title: Migraine Headaches Pictures Slideshow: 14 Non-Drug Treatments for Migraines
Created: 6/25/2012 12:00:00 AM
Last Editorial Review: 6/26/2015 12:00:00 AM
Source: MedicineNet Cauliflower Ear Specialty [2015.06.22]
Title: Tension Headache
Category: Diseases and Conditions
Created: 2/4/2005 12:00:00 AM
Last Editorial Review: 6/22/2015 12:00:00 AM
Studies at American Headache Society Meeting show promise in new migraine prevention drugs
Source: Headache / Migraine News From Medical News Today [2015.06.18]
CGRP antagonists first mechanism-specific treatments developed to prevent migraineMigraine researchers and clinicians are growing excited about a new class of drugs called Calcitonin Gene-Related...
Published Studies Related to Phrenilin (Butalbital / Acetaminophen)
Sumatriptan-Naproxen and Butalbital: A Double-Blind, Placebo-Controlled Crossover Study. [2011.11.21]
Objectives.- The primary objective was to compare the efficacy of a sumatriptan and naproxen combination medication (SumaRT/Nap-85 mg sumatriptan and 500 mg naproxen sodium), a butalbital-containing combination medication (BCM-50 mg butalbital, 325 mg acetaminophen, 40 mg caffeine), and placebo when used to treat moderate to severe migraine headache pain in subjects who used BCMs in the past.
Butalbital in the treatment of headache: history, pharmacology, and efficacy. [2001.11]
Analgesics containing butalbital compounded with aspirin, acetaminophen, and/or caffeine are widely used for the treatment of migraine and tension-type headache. The butalbital-containing compounds are efficacious in placebo-controlled trials among patients with episodic tension-type headaches.Because of concerns about overuse, medication-overuse headache, and withdrawal, their use should be limited and carefully monitored.